MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license. The affected store is located in Bangalore, Karnataka. The suspension, effective June 9, 2026, is due to alleged violations under the Drugs and Cosmetics Act, 1940. The company anticipates a potential revenue loss of approximately ₹1.48 lakhs from this event.
Subsidiary Faces Drug License Suspension
MedPlus Health Services Limited has disclosed that its subsidiary, Optival Health Solutions Private Limited, has been issued a suspension order for a drug license. The order pertains to a store situated in Karnataka and mandates a two-day suspension of operations.
Details of the Order
The suspension order was issued by the Assistant Director, Drugs Control Administration, Bangalore, on June 9, 2026. The Nature and details of the action taken is a Suspension of Drug License for two days of the store situated at Bangalore Circle-5, Kacharakanahalli, Bangalore, Karnataka. The alleged violation stems from non-compliance with provisions under Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945.
Financial Impact and Outlook
The company anticipates a potential impact on its financial operations, estimating a potential revenue loss of ₹1.48 lakhs. This figure represents the quantifiable impact to the extent possible. MedPlus Health Services Limited has ensured this information is available on its corporate website and the websites of BSE Limited and the National Stock Exchange of India Limited.
Source: BSE
